New perspectives for the treatment of pulmonary hypertension

被引：46

作者：

Baliga, Reshma S. ^{[1
]}

MacAllister, Raymond J. ^{[2
]}

Hobbs, Adrian J. ^{[1
,2
]}

机构：

[1] UCL, Dept Pharmacol, London WC1E 6BT, England

[2] UCL, Dept Clin Pharmacol, London WC1E 6BT, England

来源：

BRITISH JOURNAL OF PHARMACOLOGY | 2011年 / 163卷 / 01期

基金：

英国惠康基金; 英国医学研究理事会;

关键词：

pulmonary hypertension; cyclic GMP; guanylate cyclase; phosphodiesterase; endothelin-1; prostacyclin; tyrosine kinase; growth factors; ion channels; SOLUBLE GUANYLATE-CYCLASE; NITRIC-OXIDE SYNTHASE; ENDOTHELIN-RECEPTOR ANTAGONIST; SEROTONIN TRANSPORTER POLYMORPHISMS; VASOACTIVE-INTESTINAL-PEPTIDE; EXPERT CONSENSUS DOCUMENTS; BRAIN NATRIURETIC PEPTIDE; GROWTH-FACTOR EXPRESSION; FOUNDATION TASK-FORCE; RHO-KINASE INHIBITOR;

D O I：

10.1111/j.1476-5381.2010.01164.x

中图分类号：

R9 [药学];

学科分类号：

100702 [药剂学];

摘要：

LINKED ARTICLES This article is part of a themed issue on Respiratory Pharmacology. To view the other articles in this issue visit http://dx.doi.org/10.1111/bph.2011.163.issue-1.

引用

收藏

页码：125 / 140

页数：16

相关论文

共 195 条

[1]

Vascular actions of natriuretic peptides - Cyclic GMP-dependent and -independent mechanisms [J].

Ahluwalia, A ;

MacAllister, RJ ;

Hobbs, AJ .

BASIC RESEARCH IN CARDIOLOGY, 2004, 99 (02) :83-89

[2]

Endothelium-derived C-type natriuretic peptide: more than just a hyperpolarizing factor [J].

Ahluwalia, A ;

Hobbs, AJ .

TRENDS IN PHARMACOLOGICAL SCIENCES, 2005, 26 (03) :162-167

[3]

Alexander SPH, 2009, BRIT J PHARMACOL, V158, pS1, DOI 10.1111/j.1476-5381.2009.00499.x

[4]

Role of prostacyclin versus peroxisome proliferator-activated receptor β receptors in prostacyclin sensing by lung fibroblasts [J].

Ali, FY ;

Egan, K ;

FitzGerald, GA ;

Desvergne, B ;

Wahli, W ;

Bishop-Bailey, D ;

Warner, TD ;

Mitchell, JA .

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2006, 34 (02) :242-246

[5]

SHORT-TERM AND LONG-TERM HEMODYNAMIC-EFFECTS OF CAPTOPRIL IN PATIENTS WITH PULMONARY-HYPERTENSION AND SELECTED CONNECTIVE-TISSUE DISEASE [J].

ALPERT, MA ;

PRESSLY, TA ;

MUKERJI, V ;

LAMBERT, CR ;

MUKERJI, B .

CHEST, 1992, 102 (05) :1407-1412

[6]

Phosphodiesterase III inhibitors for heart failure [J].

Amsallem, E ;

Kasparian, C ;

Haddour, G ;

Boissel, JP ;

Nony, P .

COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2005, (01)

[7]

Nitric oxide deficiency in fenfluramine- and dexfenfluramine-induced pulmonary hypertension [J].

Archer, SL ;

Djaballah, K ;

Humbert, M ;

Weir, EK ;

Fartoukh, M ;

DalL'Ava-Santucci, J ;

Mercier, JC ;

Simonneau, G ;

Dinh-Xuan, AT .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 158 (04) :1061-1067

[8]

Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of type II bone morphogenetic protein receptor [J].

Atkinson, C ;

Stewart, S ;

Upton, PD ;

Machado, R ;

Thomson, JR ;

Trembath, RC ;

Morrell, NW .

CIRCULATION, 2002, 105 (14) :1672-1678

[9]

Longterm Survival Among Patients with Scleroderma-associated Pulmonary Arterial Hypertension Treated with Intravenous Epoprostenol [J].

Badesch, David B. ;

McGoon, Michael D. ;

Barst, Robin J. ;

Tapson, Victor F. ;

Rubin, Lewis J. ;

Wigley, Fredrick M. ;

Kral, Kenneth M. ;

Raphiou, Ibrahim H. ;

Crater, Glenn D. .

JOURNAL OF RHEUMATOLOGY, 2009, 36 (10) :2244-2249

[10]

Synergy between natriuretic peptides and phosphodiesterase 5 inhibitors ameliorates pulmonary arterial hypertension [J].

Baliga, Reshma S. ;

Zhao, Lan ;

Madhani, Melanie ;

Lopez-Torondel, Belen ;

Visintin, Cristina ;

Selwood, David ;

Wilkins, Martin R. ;

MacAllister, Raymond J. ;

Hobbs, Adrian J. .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2008, 178 (08) :861-869

← 1 2 3 4 5 6 7 8 9 10 →